menthol has been researched along with Headache in 4 studies
Menthol: A monoterpene cyclohexanol produced from mint oils.
Headache: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to determine associations between cigarette smoking and the existence of headache in a nationally representative sample, with attention to differences in effect estimates between mentholated and non-mentholated cigarettes smoking." | 7.83 | Association Between Overall and Mentholated Cigarette Smoking With Headache in a Nationally Representative Sample. ( Estus, S; Gan, WQ; Smith, JH, 2016) |
| "The objective of this study was to determine associations between cigarette smoking and the existence of headache in a nationally representative sample, with attention to differences in effect estimates between mentholated and non-mentholated cigarettes smoking." | 3.83 | Association Between Overall and Mentholated Cigarette Smoking With Headache in a Nationally Representative Sample. ( Estus, S; Gan, WQ; Smith, JH, 2016) |
| "The mean migraine duration was 18." | 3.11 | A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study. ( Arkuszewski, M; Ecochard, L; Kim, BK; Li, Z; Lian, Y; Su, W; Wan, Q; Wang, H; Wang, SJ; Wen, S; Yin, F; Yu, S; Yu, T; Zhou, J, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, S | 3 |
| Kim, BK | 3 |
| Wang, H | 3 |
| Zhou, J | 3 |
| Wan, Q | 3 |
| Yu, T | 3 |
| Lian, Y | 3 |
| Arkuszewski, M | 3 |
| Ecochard, L | 3 |
| Wen, S | 3 |
| Yin, F | 3 |
| Li, Z | 3 |
| Su, W | 3 |
| Wang, SJ | 3 |
| D'Ruiz, CD | 1 |
| Graff, DW | 1 |
| Yan, XS | 1 |
| Gan, WQ | 1 |
| Estus, S | 1 |
| Smith, JH | 1 |
| PAPA, CM | 1 |
| SHELLEY, WB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Characterization of Nicotine Exposure and Urge-to-Smoke Following a Single Controlled Administration and Short-Term Ad Lib Use of Electronic Cigarettes and Conventional Cigarettes in Adult Smokers[NCT02210754] | 24 participants (Actual) | Interventional | 2014-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for menthol and Headache
| Article | Year |
|---|---|
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
Nicotine delivery, tolerability and reduction of smoking urge in smokers following short-term use of one brand of electronic cigarettes.
Topics: Adult; Cough; Craving; Cross-Over Studies; Dizziness; Electronic Nicotine Delivery Systems; Female; | 2015 |
2 other studies available for menthol and Headache
| Article | Year |
|---|---|
Association Between Overall and Mentholated Cigarette Smoking With Headache in a Nationally Representative Sample.
Topics: Adult; Cross-Sectional Studies; Female; Headache; Humans; Male; Menthol; Middle Aged; Nutrition Surv | 2016 |
MENTHOL HYPERSENSITIVITY; DIAGNOSTIC BASOPHIL RESPONSE IN A PATIENT WITH CHRONIC URTICARIA, FLUSHING, AND HEADACHES.
Topics: Basophils; Dentifrices; Drug Hypersensitivity; Headache; Humans; Hypersensitivity; Leukocyte Count; | 1964 |